Dihydroergotamine (DHE) may be considered if first-line treatments like triptans are ineffective. DHE can be administered through IV infusion, injection, or nasal spray. People who are pregnant or ...
September 16, 2009 (Philadelphia, Pennsylvania) — In a phase 3 trial of a novel, orally inhaled formulation of dihydroergotamine (DHE; Levadex, MAP Pharmaceuticals) for the treatment of acute migraine ...
Migraine pathophysiology continues to evolve, and additional therapeutic receptors influencing unrecognized neural networks within the cortex, brainstem and cerebral vasculature likely exist.
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced the advancement of two key strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results